Sutib 12.5mg Capsule (Sunitinib)
Sutib 12.5mg Capsule (Sunitinib)

Sutib 12.5mg Capsule (Sunitinib)

prescriptionImage Prescription Required

Manufactured By

Glenmark

Pack Of

28

Salt Composition

Sunitinib

Storage

Keep in cold place

Safe and Secure


Your health and safety are our top priority. All our medicines are sourced from trusted suppliers, thoroughly tested, and approved for use. We follow strict quality control standards to ensure every product is safe, effective, and reliable. Shop with confidence knowing your wellness is in good hands.

Fast Delivery

Fast Delivery

Easy Returns

Easy Returns

Secure Payments

Secure Payments

Up to 60% Discounts

Up to 60% Discounts

ALL SUBSTITUTES

Sutent 50mg Capsule

Sutent 50mg Capsule

Sunicine 50mg Capsule

Sunicine 50mg Capsule

Sutinat 12.5mg Capsule

Sutinat 12.5mg Capsule

Nitnib 12.5mg Capsule

Nitnib 12.5mg Capsule

Sutenamo 25mg Capsule

Sutenamo 25mg Capsule

Sunitcap 25mg Capsule

Sunitcap 25mg Capsule

Sunitcap 12.5mg Capsule

Sunitcap 12.5mg Capsule

Sunisam 12.5mg Capsule

Sunisam 12.5mg Capsule

Sugistran 12.5mg Capsule

Sugistran 12.5mg Capsule

Tunib 25mg Capsule

Tunib 25mg Capsule

Sutib 25mg Capsule

Sutib 25mg Capsule

Svitinib 25mg Capsule

Svitinib 25mg Capsule

Adsunib 12.5mg Capsule

Adsunib 12.5mg Capsule

Healtinib 50mg Capsule

Healtinib 50mg Capsule

Tunib 12.5mg Capsule

Tunib 12.5mg Capsule

Sutekast 12.5mg Capsule

Sutekast 12.5mg Capsule

Sunicine 12.5mg Capsule

Sunicine 12.5mg Capsule

Sunicine 25mg Capsule

Sunicine 25mg Capsule

Sutent 25mg Capsule

Sutent 25mg Capsule

Sutent 12.5mg Capsule

Sutent 12.5mg Capsule

Sutinat 50mg Capsule

Sutinat 50mg Capsule

Sutinat 25mg Capsule

Sutinat 25mg Capsule

Overview

Sutib 12.5mg Capsule is an anticancer medicine prescribed to certain types of kidney cancer, gastrointestinal stromal tumor, pancreatic neuroendocrine tumors, and medullary thyroid cancer. It contains Sunitinib as an active ingredient that works by blocking the action of specific enzyme.

It effectively controls the progression of cancer, especially in the advance stages of cancer. It may take few weeks to few months to see the results so don't stop taking medicine on your own without informing your doctor.

Quick Product Facts

FieldPublication wording
Brandsutib
Generic / Active IngredientSunitinib
Strength12.5
Dosage FormCapsule
Manufacturer / Marketerglenmark
Pack Size28
Prescription RequiredYes
Therapeutic CategoriesCancer Medicines
UsesGastrointestinal Stromal Tumors

Uses and Indications

Kidney Cancer,  Gastrointestinal stromal tumors

Side Effects of Sutib 12.5mg Capsule

Like other anticancer medicines, Sutib 12.5mg Capsule(Sunitinib 12.5mg) also has some common to severe side effects. These undesired symptoms observed in the body after taking this medicine and usually disappear with time as the body adjusts to the medicine.
Common Side Effects Include:
● Decreased appetite
● Mucositis
● High blood pressure
● Hand-foot syndrome
● Bleeding disorder
● Taste change
● Nausea
● Vomiting
● Weakness
● Fatigue
● Diarrhea
Above mentioned effects don't need any special medical attention, but if you observe them continually, talk to your doctor immediately.

Sutib 12.5mg Capsule Dosage and How To Take It

The recommended dose Sutib 12.5mg Capsule(Sunitinib 12.5mg) may vary according to the type & stage of cancer, or age, weight, and other health factors of the patients. This capsule should be swallowed as a whole with water and do not crush, chew, or open it. It is usually taken once a day, with or without food, at a fixed time each day. Don't miss a dose or double the dose to compensate for the missed dose.

Safety Advice for Sutib 12.5mg Capsule

  • ● Alcohol: Avoid the consumption of alcohol while taking Sutib 12.5mg Capsule(Sunitinib 12.5mg), as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
  • ● Pregnancy: Do not take the Sutib 12.5mg Capsule without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
  • ● Breastfeeding: Sutib 12.5mg Capsule(Sunitinib 12.5mg) is unsafe to use during breastfeeding as it may cause toxicity to the baby.
  • ● Driving: Sutib 12.5mg Capsule is usually consider safe in case of driving as it does not affect your ability to drive.
  • ● Kidney: Consumption of Sutib 12.5mg Capsule(Sunitinib 12.5mg) should be avoided without informing the doctor if you have any kidney-related issues.
  • ● Liver: Consumption of Sutib 12.5mg Capsule should be avoided without informing the doctor if you have any liver-related issues.

FAQs About Sutib 12.5mg Capsule

What are the uses of Sutib 12.5mg Capsule(Sunitinib 12.5mg)?

downArrowImg

Sutib 12.5mg is a prescription based anticancer medicine used in the treatment of kidney cancer, gastrointestinal stromal tumor, pancreatic neuroendocrine tumors, and medullary thyroid cancer.

How to take Sutib 12.5mg Capsule?

downArrowImg

Take Sutib 12.5mg(Sunitinib 12.5mg capsule) exactly as prescribed by the doctor at a same time each day.


Can a liver or kidney related issue patient can take it?

downArrowImg

It is advice to avoid the consumption of Sutib 12.5mg Capsule(Sunitinib 12.5mg) in case of kidney or liver related issues.

How does Sutib 12.5mg Capsule work?

downArrowImg

It contains Sunitinib as an active ingredient that works by blocking the action of specific enzyme responsible for the growth of cancer cells.

What are the common side effects of taking Sutib 12.5mg Capsule?

downArrowImg

There are some possible side effects of taking Sutib 12.5mg Capsule(Sunitinib 12.5mg) such as taste change, nausea, vomiting, weakness, fatigue, diarrhea, etc.

References

● Motzer, R. J., Michaelson, M. D., Rosenberg, J., Bukowski, R. M., Curti, B. D., George, D. J., ... & Wilding, G. (2007). Sunitinib efficacy against advanced renal cell carcinoma. The Journal of urology, 178(5), 1883-1887.
● Motzer, R. J., Escudier, B., Gannon, A., & Figlin, R. A. (2017). Sunitinib: ten years of successful clinical use and study in advanced renal cell carcinoma. The oncologist, 22(1), 41-52.
● Raymond, E., Dahan, L., Raoul, J. L., Bang, Y. J., Borbath, I., Lombard-Bohas, C., ... & Ruszniewski, P. (2011). Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. New England Journal of Medicine, 364(6), 501-513.
● Gan, H. K., Seruga, B., & Knox, J. J. (2009). Sunitinib in solid tumors. Expert opinion on investigational drugs, 18(6), 821-834.
● Rini, B. I. (2007). Sunitinib. Expert opinion on pharmacotherapy, 8(14), 2359-2369.

Marketer Details

Glenmark

Rating and Reviews

⭐ 4.4/5

9 Reviews

Kevin - ⭐ 1/5

Worst Experience Ever

Author Details

logoImg

Written By:

Nonish Sharma

I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More


reviewerImg

Reviewed By:

Vaibhav Shakya

Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More

Last Updated: 12 Oct 2026 | 06:21 am (IST)

Want to know More

Check our Editor Policy

Disclaimer

Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.

Chat on WhatsApp